bioMérieux S.A. (BMXMF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 10:56AM EDT. Market open.
Show:
Annual
Income statement
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,674,600
3,674,600
3,589,000
3,376,200
3,118,100
Cost of revenue
1,617,400
1,617,400
1,580,400
1,375,400
1,364,500
Gross profit
2,057,200
2,057,200
2,008,600
2,000,800
1,753,600
Operating expenses
Research development
460,100
460,100
446,600
385,800
398,800
Selling general and administrative
1,020,500
1,020,500
954,700
815,600
789,300
Total operating expenses
1,488,300
1,488,300
1,382,900
1,156,800
1,141,200
Operating income or loss
568,900
568,900
625,700
844,000
612,400
Interest expense
4,400
4,400
4,100
9,100
24,900
Income before tax
437,500
437,500
580,500
774,500
524,400
Income tax expense
114,500
114,500
140,100
175,600
121,500
Income from continuing operations
323,000
323,000
440,400
598,200
402,700
Net income
357,600
357,600
452,400
601,100
404,400
Net income available to common shareholders
357,600
357,600
452,400
601,100
404,400
Basic EPS
3.28
3.03
3.84
5.08
3.42
Diluted EPS
3.25
3.01
3.82
5.06
3.41
Basic average shares
117,831
118,154
117,946
118,265
118,147
Diluted average shares
118,573
118,802
118,441
118,893
118,652
© 2024 Yahoo. All rights reserved.